An overview of sexually transmitted diseases. Part III ... - Dermatology

J AM ACAD DERMATOL
VOLUME 43, NUMBER 3
81. Hook EW, Marra CM. Acquired syphilis in adults. N Engl J Med
1992;326:1060-9.
82. Katz DA, Berger JR, Duncan RC. Neurosyphilis: a comparative
study of the effects of infection with HIV. Arch Neurol
1993;50:243-9.
83. Malone JL, Wallace MR, Hendrick BB, La Rocco A, Tonon E,
Brodine SK, et al. Syphilis and neurosyphilis in a HIV type-1
seropositive population: evidence for frequent serologic
relapse after therapy. Am J Med 1995;99:55-63.
84. Rolfs RT. Treatment of syphilis, 1993. Clin Infect Dis
1995;20(Suppl 1):S23-S38.
85. Dibbern DA, Ray SC. Recrudescence of treated neurosyphilis in
a patient with human immunodeficiency virus. Mayo Clin Proc
1999;74:53-6.
86. Morgello S, Laufer H. Quarternary neurosyphilis in a Haitian
man with human immunodeficiency virus infection. Hum
Pathol 1989;20:808-11.
87. Hay P, Tam F, Kitchen V, Horner S, Bridger J, Weber J, et al.
Gummatous lesions in men infected with human immunodeficiency
virus and syphilis. Genitourin Med 1990;66:374-9.
88. McLeish W, Pulido J, Holland S, Culbertson WW,Winward K.The
ocular manifestations of syphilis in the human immunodeficiency
virus type 1 infected host. Ophthalmology 1990;97:
196-203.
89. Shalaby IA, Dunn JP, Semba RD, Jabs DA. Syphilitic uveitis in
HIV-infected patients. Arch Ophthalmol 1997;115:469-73.
90. Olmos JM, Fernandez-Ayala M, Gutierrez JA, Val JF, Gonzalez-
Marcias J. Superior vena cava syndrome secondary to
syphilitic aneurysm of the ascending aorta in a human
immunodeficiency virus-infected patient. Clin Infect Dis 1998;
27:1331-2.
91. Rompalo AM, Cannon RO, Quinn TC, Hook EW. Association of
biologic false-positive reactions for syphilis with human
immunodeficiency virus infection. J Infect Dis 1992;165:1124-
6.
92. Capoccia A, Ranieri R, Busnelli M, Passaretti B, Milella AM,
Vecchi L. Serologic study on the prevalence of HIV, HBV infection
and on the false-positive reaction of VDRL at a prison.
Minerva Med 1991;82:125-30.
93. Joyanes B, Borobio MV, Arquez JM, Perea EJ.The association of
false-positive rapid plasma reagin results and HIV infection.
Sex Transm Dis 1998;25:569-71.
94. Hernandez-Aguado I, Bolumar F, Moreno R, Pardo FJ, Torres N,
Belda J, Espacio A. False-positive tests for syphilis associated
with human immunodeficiency virus and hepatitis B virus
infection among intravenous drug abusers: Valencia Study
Group on HIV Epidemiology. Eur J Clin Microbiol Infect Dis
1998;17:784-7.
95. Goeman J, Kivuvu M, Nzila N, Behets F, Edidi B, Gneore E, et al.
Similar serological response to conventional therapy for
syphilis among HIV-positive and HIV-negative women.
Genitourin Med 1995;71:275-9.
96. Gourevitch MN, Selwyn PA, Davenny K, Buono D, Schoenbaum
EE, Klein RS, et al. Effects of HIV infection on the serologic manifestations
and response to treatment of syphilis in intravenous
drug users. Ann Intern Med 1993;118:350-5.
97. Marra CM, Longstreth WT, Maxwell C, Lukehart SA. Resolution
of serum and cerebrospinal fluid abnormalities after treatment
of neurosyphilis: influence of concomitant HIV infection.
Sex Transm Dis 1996;23:184-9.
98. Telzak EE, Greenburg MS, Harrison J, Stoneburner RL, Schultz S.
Syphilis treatment response in HIV-infected individuals. AIDS
1991;5:591-5.
99. Yinnon AM, Coury-Doniger P, Polito R, Reichman RC. Serologic
response to treatment of syphilis in patients with HIV infection.
Arch Intern Med 1996;156:321-5.
Czelusta, Yen-Moore, and Tyring 427
100. Hicks CB, Benson PM, Lupton GP, Tramont EC. Seronegative
secondary syphilis in a patient infected with the human
immunodeficiency virus (HIV) with Kaposi’s sarcoma. Ann
Intern Med 1987;107:492-5.
101. Radolf JD, Kaplan RP. Unusual manifestations of secondary
syphilis and abnormal humoral immune response to
Treponema pallidum antigens in a homosexual man with
asymptomatic human immunodeficiency virus infection. J Am
Acad Dermatol 1988;18:423-8.
102. Bowen DL, Lane HC, Fauci AS. Immunopathogenesis of the
acquired immunodeficiency syndrome. Ann Intern Med 1985;
103:704-9.
103. Hutchinson CM, Rompalo AM, Reichart CA, Hook EW.
Characteristics of syphilis patients attending Baltimore STD
clinics: multiple high risk subgroups and interactions with HIV
infection. Arch Intern Med 1991;151:511-6.
104. Tikjob G, Russel M, Petersen CS, Gerstoft J, Kobayasi T.
Seronegative secondary syphilis in a patient with AIDS: identification
of Treponema pallidum in a biopsy specimen. J Am
Acad Dermatol 1991;24:506-8.
105. Johnson PD, Graves SR, Stewart L,Warren R, Dwyer B, Lucas CR.
Specific syphilis serological tests may become negative in HIV
infection. AIDS 1991;5:419-23.
106. Fonseca E, Garcia-Silva J, del Pozo J, Yebra MT, Cuervas J,
Contreras F. Syphilis in an HIV-infected patient misdiagnosed
as leprosy. J Cutan Pathol 1999;26:51-4.
107. Bogaerts J, Ricart CA,Van Dyck E, Piot P.The etiology of genital
ulceration in Rwanda. Sex Transm Dis 1989;16:123-6.
108. Schmid GP, Sanders LL, Blount JH, Alexander ER. Chancroid in
the United States: reestablishment of an old disease. JAMA
1987;258:3265-8.
109. Jones C, Rosen T, Clarridge J, Collins S. Chancroid: results from
an outbreak in Houston, Texas. South Med J 1990;83:1384-8.
110. Ortiz-Zepeda C, Hernandez-Perez E, Marroquin-Burgos R.
Gross and microscopic features in chancroid: a study in 200
new culture-proven cases in San Salvador. Sex Transm Dis
1994;21:112-7.
111. Manget-Velasco CS, Borbujo-Martinez J, Manzano-de
Arostegui JA, Calderon-Ubeda J, Toribio-Da Pena R, Casado-
Jiminez M. Soft chancroid: 4 clinical cases. Atencion Primaria
1993;12:667-70.
112. Tyndall MW, Plourde PJ, Agoki E, Malisa W, Ndinya-Achola JO,
Plummer FA, et al. Fleroxacin in the treatment of chancroid: an
open study in men seropositive or seronegative for the
human immunodeficiency virus type 1. Am J Med 1993;
94(Suppl 3A):85S-8S.
113. Kimani J, Bwayo JJ, Anzala AO, MacLean I, Mwatha A, Choudri
SH. Low dose erythromycin regimen for the treatment of
chancroid. East Afr Med J 1995;72:645-8.
114. King R, Choudhri SH, Nasio J, Gough J, Nagelkerke NJ, Plummer
FA, et al. Clinical and in situ cellular responses to Haemophilus
ducreyi in the presence or absence of HIV infection. Int J STD
AIDS 1998;9:531-6.
115. Quale J, Teplitz E, Augenbraun M. Atypical presentation of
chancroid in a patient infected with the human immunodeficiency
virus. Am J Med 1990;88(5N):43N-44N.
116. Magro CM, Crowson AN, Alfa M, Nath A, Ronald A, Ndinya-
Achola JO. A morphological study of penile chancroid lesions
in human immunodeficiency virus (HIV)-positive and -negative
African men with a hypothesis concerning the role of
chancroid in HIV transmission. Hum Pathol 1996;27:1066-70.
117. MacDonald KS, Cameron DW, D’Costa LJ, Ndinya-Achola JO,
Plummer FA, Ronald AR. Evaluation of fleroxacin (RO 23-6240)
as single-oral-dose therapy of culture-proven chancroid in
Nairobi, Kenya. Antimicrob Agents Chemother 1989;33:612-4.
118. Plourde PJ, D’Costa LJ, Agoki E, Ombette J, Ndinya-Achola JO,